Your browser doesn't support javascript.
loading
Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors.
Vidilaseris, Keni; Johansson, Niklas G; Turku, Ainoleena; Kiriazis, Alexandros; Boije Af Gennäs, Gustav; Yli-Kauhaluoma, Jari; Xhaard, Henri; Goldman, Adrian.
Affiliation
  • Vidilaseris K; Research Program in Molecular and Integrative Biosciences, University of Helsinki.
  • Johansson NG; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki.
  • Turku A; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki.
  • Kiriazis A; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki.
  • Boije Af Gennäs G; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki.
  • Yli-Kauhaluoma J; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki.
  • Xhaard H; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki.
  • Goldman A; Research Program in Molecular and Integrative Biosciences, University of Helsinki; School of Biomedical Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds; a.goldman@leeds.ac.uk.
J Vis Exp ; (153)2019 11 23.
Article in En | MEDLINE | ID: mdl-31814619
ABSTRACT
Membrane-bound pyrophosphatases (mPPases) are dimeric enzymes that occur in bacteria, archaea, plants, and protist parasites. These proteins cleave pyrophosphate into two orthophosphate molecules, which is coupled with proton and/or sodium ion pumping across the membrane. Since no homologous proteins occur in animals and humans, mPPases are good candidates in the design of potential drug targets. Here we present a detailed protocol to screen for mPPase inhibitors utilizing the molybdenum blue reaction in a 96 well plate system. We use mPPase from the thermophilic bacterium Thermotoga maritima (TmPPase) as a model enzyme. This protocol is simple and inexpensive, producing a consistent and robust result. It takes only about one hour to complete the activity assay protocol from the start of the assay until the absorbance measurement. Since the blue color produced in this assay is stable for a long period of time, subsequent assay(s) can be performed immediately after the previous batch, and the absorbance can be measured later for all batches at once. The drawback of this protocol is that it is done manually and thus can be exhausting as well as require good skills of pipetting and time keeping. Furthermore, the arsenite-citrate solution used in this assay contains sodium arsenite, which is toxic and should be handled with necessary precautions.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrophosphatases / Thermotoga maritima / Drug Evaluation, Preclinical / Enzyme Inhibitors / Anti-Bacterial Agents Type of study: Diagnostic_studies / Screening_studies Language: En Journal: J Vis Exp Year: 2019 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrophosphatases / Thermotoga maritima / Drug Evaluation, Preclinical / Enzyme Inhibitors / Anti-Bacterial Agents Type of study: Diagnostic_studies / Screening_studies Language: En Journal: J Vis Exp Year: 2019 Document type: Article